MitoChem Therapeutics is a preclinical stage pharmaceutical company based out of Charleston, South Carolina, United States. The company is focused on developing mitochondrial protective therapeutics for rare and challenging diseases, operating within the industries of Biotechnology, Health Care, Health and Wellness, Life Sciences, and Pharmaceuticals. Established in 2011, MitoChem Therapeutics aims to address critical unmet medical needs through innovative therapeutic solutions. Currently, there is no available data regarding the company's last investment or the involved investors.
MitoChem Therapeutics
Mitochondrial protective therapeutics for rare and challenging diseases.
Founded 2011
Charleston, United States
4 employees
Venture round
Biotechnology, Health Care +3
Charleston, United States
4 employees
Venture round
Biotechnology, Health Care +3
General Information
Company Name
MitoChem Therapeutics
Founded Year
2011
Location
Charleston, United States
Charleston, United States
Employees
4
Industries
Biotechnology, Health Care, Health and Wellness +2
Funding Stage
Venture round
BounceWatch is an independent company data service, not affiliated with MitoChem Therapeutics. To contact MitoChem Therapeutics, visit mitocheminc.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does MitoChem Therapeutics compare?
A PDF of MitoChem Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting MitoChem Therapeutics soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
United States Market
Biotechnology
About MitoChem Therapeutics
No funding data available for MitoChem Therapeutics yet.
MitoChem Therapeutics Alternatives & Competitors
View All Alternatives
MitoChem Therapeutics vs
Advancing antibody therapeutics for combating diseases and targeting various biological threats.
Seed
Biotechnology, Pharmaceutical
MitoChem Therapeutics vs
CLARITY PHARMA RESEARCH LLC
United States
Providing real world evidence: pharmaceutical and medical device research based in science
2 employees
Biotechnology, Pharmaceutical
MitoChem Therapeutics vs
Nobias Therapeutics
United States
Clinical-stage company developing novel small molecule therapeutics for rare diseases
Series A
12 employees
Health Care, Health and Wellness
FAQ About MitoChem Therapeutics
Mitochondrial protective therapeutics for rare and challenging diseases.
MitoChem Therapeutics was founded in 2011.
MitoChem Therapeutics is headquartered in Charleston, United States.
MitoChem Therapeutics operates in Biotechnology, Health Care, Health and Wellness, Life Sciences and Pharmaceutical.
MitoChem Therapeutics has approximately 4 employees.
Top alternatives and competitors to MitoChem Therapeutics include Immunologix, Inc., CLARITY PHARMA RESEARCH LLC, Nobias Therapeutics, Seelos Therapeutics, Inc., Nuvamid. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
MitoChem Therapeutics and Immunologix, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Source: BounceWatch company record for MitoChem Therapeutics, https://bouncewatch.com/company/mitochem-therapeutics, updated 20 December 2024. When citing, please name BounceWatch and link this page.
